Aurion Biotech recently completed a Phase 1 / 2 clinical trial with 97 patients in the U.S. and Canada. The company's cell therapy has also been approved for use in Japan.
Organizations Involved
CorneaGen, Kyoto Prefecture University of Medicine
Founders
Greg Kunst
Market
Vision Restoration
Location
Seattle, WA, US
Company Description
Aurion Biotechnologies is a clinical-stage biotech company.